Complications, n (%) | ESRD | No ESRD | P value |
Volume overload | 19 (28) | 7 (3) | <0.001 |
Mechanical ventilation | 16 (24) | 6 (3) | <0.001 |
Sepsis | 15 (22) | 8 (3) | <0.001 |
Myocardial infarction | 7 (10) | 1 (0.4) | <0.001 |
Rhabdomyolysis | 3 (4) | 0 (0) | 0.01 |
Deep venous thrombosis | 5 (7) | 2 (1) | 0.007 |
Pulmonary emboli | 1 (1) | 2 (1) | 0.53 |
Mortality hospital | 2 (3) | 0 (0) | 0.21 |
Mortality 30 days | 7 (10) | 2 (1) | <0.001 |
Mortality 365 days | 12 (18) | 3 (1) | <0.001 |
Length of stay, median days (Q1–Q3) | 7.0 (4.0–12.5) | 3.0 (2.0–4.0) | <0.001 |
Hospital costs, median US$ (Q1–Q3) | 50 844 (31 503–77 730) | 14 252 (10 003–23 886) | <0.001 |
ESRD, end-stage renal disease.